GB0507386D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0507386D0
GB0507386D0 GB0507386A GB0507386A GB0507386D0 GB 0507386 D0 GB0507386 D0 GB 0507386D0 GB 0507386 A GB0507386 A GB 0507386A GB 0507386 A GB0507386 A GB 0507386A GB 0507386 D0 GB0507386 D0 GB 0507386D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0507386A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0507386A priority Critical patent/GB0507386D0/en
Publication of GB0507386D0 publication Critical patent/GB0507386D0/en
Priority to PE2005000983A priority patent/PE20060653A1/en
Priority to RU2007111893/04A priority patent/RU2409582C2/en
Priority to KR1020077007190A priority patent/KR20070057885A/en
Priority to CA002578781A priority patent/CA2578781A1/en
Priority to CN2005800372427A priority patent/CN101048414B/en
Priority to MX2007002548A priority patent/MX2007002548A/en
Priority to NZ553506A priority patent/NZ553506A/en
Priority to TW094129416A priority patent/TW200619221A/en
Priority to JP2007528777A priority patent/JP2008511574A/en
Priority to PCT/EP2005/009379 priority patent/WO2006024517A1/en
Priority to ARP050103607A priority patent/AR053307A1/en
Priority to EP05778196A priority patent/EP1786822A1/en
Priority to AU2005279278A priority patent/AU2005279278A1/en
Priority to BRPI0514377-2A priority patent/BRPI0514377A/en
Priority to US11/574,450 priority patent/US20120022056A1/en
Priority to IL181387A priority patent/IL181387A/en
Priority to NO20071326A priority patent/NO20071326L/en
Priority to MA29771A priority patent/MA28871B1/en
Ceased legal-status Critical Current

Links

GB0507386A 2004-08-31 2005-04-12 Compounds Ceased GB0507386D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0507386A GB0507386D0 (en) 2005-04-12 2005-04-12 Compounds
PE2005000983A PE20060653A1 (en) 2004-08-31 2005-08-26 CONDENSED TRICYCLIC DERIVATIVES AS 5-HT1 RECEIVER MODULATORS
US11/574,450 US20120022056A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
TW094129416A TW200619221A (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives
ARP050103607A AR053307A1 (en) 2004-08-31 2005-08-29 COMPOSITE OF FUSIONATED TRICICLIC RINGS, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
CA002578781A CA2578781A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
CN2005800372427A CN101048414B (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
MX2007002548A MX2007002548A (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders.
NZ553506A NZ553506A (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
RU2007111893/04A RU2409582C2 (en) 2004-08-31 2005-08-29 Condensed tricyclic derivatives for treating psychotic disorders
JP2007528777A JP2008511574A (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychiatric disorders
PCT/EP2005/009379 WO2006024517A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
KR1020077007190A KR20070057885A (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
EP05778196A EP1786822A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
AU2005279278A AU2005279278A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders
BRPI0514377-2A BRPI0514377A (en) 2004-08-31 2005-08-29 fused tricyclic derivatives for the treatment of psychotic disorders
IL181387A IL181387A (en) 2004-08-31 2007-02-15 Fused tricyclic derivatives for the treatment of psychotic disorders
NO20071326A NO20071326L (en) 2004-08-31 2007-03-12 Condensed tricyclic derivatives for the treatment of psychotic disorders
MA29771A MA28871B1 (en) 2004-08-31 2007-03-23 ACCURATE TRICYCLIC DERIVATIVES FOR THE TREATMENT OF PSYCHOTIC DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0507386A GB0507386D0 (en) 2005-04-12 2005-04-12 Compounds

Publications (1)

Publication Number Publication Date
GB0507386D0 true GB0507386D0 (en) 2005-05-18

Family

ID=34611000

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0507386A Ceased GB0507386D0 (en) 2004-08-31 2005-04-12 Compounds

Country Status (1)

Country Link
GB (1) GB0507386D0 (en)

Similar Documents

Publication Publication Date Title
GB0508472D0 (en) Compounds
GB0503962D0 (en) Compounds
GB0514478D0 (en) Compounds
GB0507602D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0502316D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0508463D0 (en) Compounds
GB0502310D0 (en) Compounds
GB0502299D0 (en) Compounds
EP1888082A4 (en) Motilide compounds
GB0505084D0 (en) Compounds
GB0503961D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0506467D0 (en) Compounds
GB0505086D0 (en) Compounds
GB0508460D0 (en) Compounds
GB0505509D0 (en) Compounds
GB0505735D0 (en) Compounds
GB0501985D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
GB0503145D0 (en) Compounds
GB0507597D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)